Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Heuser · SciRah

Researcher profile · Semantic Scholar

M. Heuser

Share profile

M. Heuser — researcher profile on SciRah

h-index: 76
Works: 563
Citations: 23K

Most-cited papers

Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.
P. Montesinos, C. Récher, S. Vives, E. Zarzycka +12 more
2022New England Journal of Medicine402 citations Open access
Semantic Scholar
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax
A. Waclawiczek, Aino-Maija Leppä, S. Renders, Karolin Stumpf +20 more
2023Cancer Discovery95 citations Open access
Semantic Scholar
Molecular taxonomy of myelodysplastic syndromes and its clinical implications
Elsa Bernard, R. Hasserjian, Peter L. Greenberg, J. A. Arango Ossa +53 more
2024Blood63 citations Open access
Semantic Scholar
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.
Maria Sirenko, Elsa Bernard, M. Creignou, D. Domenico +56 more
2024Blood58 citations Open access
Semantic Scholar
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
H. Döhner, D. Weber, J. Krzykalla, W. Fiedler +33 more
2023The Lancet Haematology55 citations
Semantic Scholar
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C. Buske, M. Dreyling, A. Álvarez-Larrán, J. Apperley +32 more
2022ESMO Open48 citations Open access
Semantic Scholar
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
N. Gagelmann, A. Badbaran, R. Salit, T. Schroeder +14 more
2023Blood46 citations Open access
Semantic Scholar
Clonal Relapse Dynamics in Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation.
C. Wienecke, B. Heida, L. Venturini, R. Gabdoulline +13 more
2024Blood40 citations
Semantic Scholar
Using Measurable Residual Disease to Optimize Management of AML, ALL, and Chronic Myeloid Leukemia.
Simone E. Dekker, D. Réa, J. Cayuela, Isabell Arnhardt +2 more
2023American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting39 citations Open access
Semantic Scholar
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
N. Jahn, E. Jahn, Maral Saadati, L. Bullinger +20 more
2022Leukemia39 citations Open access
Semantic Scholar
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study
Alberto Hernández-Sánchez, T. González, M. Sobas, E. Sträng +26 more
2024Leukemia35 citations Open access
Semantic Scholar
Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients
V. Panagiota, Johanna Franziska Kerschbaum, O. Penack, Catarina M Stein +24 more
2023HemaSphere35 citations Open access
Semantic Scholar
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial
H. Zimmermann, C. Koenecke, M. Dreyling, C. Pott +14 more
2022Leukemia34 citations Open access
Semantic Scholar
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosis
N. Gagelmann, C. Wolschke, R. Salit, T. Schroeder +11 more
2022Blood Advances33 citations Open access
Semantic Scholar
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis
N. Gagelmann, Gabriela S. Hobbs, E. Campodonico, G. Helbig +26 more
2024American journal of hematology/oncology28 citations Open access
Semantic Scholar
Measurable Residual Disease Monitoring in Patients with Acute Myeloid Leukemia Treated with Lower Intensity Therapy: Roadmap from an ELN-DAVID Expert Panel
F. Ravandi, Jacqueline Cloos, F. Buccisano, R. Dillon +13 more
2023American journal of hematology/oncology28 citations Open access
Semantic Scholar
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients
Adriane Halik, Marlon Tilgner, Patricia Silva, Natalia Estrada +28 more
2024Journal of Hematology & Oncology26 citations Open access
Semantic Scholar
Resistance to targeted therapies in acute myeloid leukemia
R. Mecklenbrauck, M. Heuser
2022Clinical and Experimental Metastasis26 citations Open access
Semantic Scholar
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia
R. Shahswar, G. Beutel, R. Gabdoulline, A. Schwarzer +16 more
2023Haematologica23 citations Open access
Semantic Scholar
Molecular Taxonomy of Myelodysplastic Syndromes and Its Clinical Implications
E. Bernard, R. Hasserjian, Peter L. Greenberg, J. A. Arango Ossa +49 more
2023Blood21 citations Open access
Semantic Scholar
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
J. Takeda, K. Yoshida, M. Nakagawa, Y. Nannya +37 more
2022Blood Cancer Discovery21 citations Open access
Semantic Scholar
Updated efficacy and safety data from the AGILE study in patients with newly diagnosed acute myeloid leukemia treated with ivosidenib + azacitidine compared to placebo + azacitidine.
S. de Botton, P. Montesinos, Susana Vives Polo, E. Zarzycka +11 more
2023Journal of Clinical Oncology19 citations
Semantic Scholar
Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review.
M. Heuser, C. Fernandez, O. Hauch, Olga M. Klibanov +2 more
2023Future Oncology18 citations Open access
Semantic Scholar
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease
J. Heitmann, R. Schlenk, D. Dörfel, S. Kayser +14 more
2023Journal of Hematology & Oncology17 citations Open access
Semantic Scholar
Non-viral TRAC-knocked-in CD19KICAR-T and gp350KICAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency
Tobias Braun, Alina Pruene, M. Darguzyte, A. V. Vom Stein +13 more
2023Frontiers in Immunology16 citations Open access
Semantic Scholar
Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria
M. Tometten, M. Kirschner, R. Meyer, M. Begemann +20 more
2023HemaSphere13 citations Open access
Semantic Scholar
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
I. Abou Dalle, M. Labopin, N. Kröger, T. Schroeder +19 more
2023Bone Marrow Transplantation12 citations Open access
Semantic Scholar
Machine Learning Allows the Identification of New Co-Mutational Patterns with Prognostic Implications in NPM1 Mutated AML - Results of the European Harmony Alliance
A. Hernández Sánchez, Ángela Villaverde Ramiro, E. Sträng, Castellani Gastone +33 more
2022Blood12 citations
Semantic Scholar
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative Analysis
N. Gagelmann, R. Salit, T. Schroeder, A. Badbaran +10 more
2022HemaSphere11 citations Open access
Semantic Scholar
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis
D. Luque Paz, N. Gagelmann, L. Benajiba, J. Riou +26 more
2024Blood Advances10 citations Open access
Semantic Scholar
Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia
R. Schlenk, D. Weber, J. Krzykalla, T. Kindler +17 more
2023Scientific Reports9 citations Open access
Semantic Scholar
Machine Learning Provides Individualized Prediction of Outcomes after First Complete Remission in Adult AML Patients - Results from the Harmony Platform
A. Hernández Sánchez, Javier Martínez Elicegui, M. Sobas, E. Sträng +37 more
2023Blood9 citations
Semantic Scholar
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
P. Klement, W. Fiedler, R. Gabdoulline, Louisa-Kristin Dallmann +25 more
2022Annals of Hematology9 citations Open access
Semantic Scholar
Oral Abstract: AML-295 AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib + Azacitidine Versus Placebo + Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 Mutation
H. Döhner, P. Montesinos, S. Polo, E. Zarzycka +14 more
2022Clinical Lymphoma, Myeloma & Leukemia9 citations
Semantic Scholar
Understanding differential technologies for detection of MRD and how to incorporate into clinical practice.
Jacqueline Cloos, Lam-Ngai Lok, M. Heuser
2023Hematology. American Society of Hematology. Education Program8 citations Open access
Semantic Scholar
In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts
G. Greve, G. Andrieux, P. Schlosser, Nadja Blagitko-Dorfs +13 more
2023Leukemia7 citations Open access
Semantic Scholar
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy
D. Frank, P. Patnana, J. Vorwerk, Lianghao Mao +55 more
2023Blood7 citations Open access
Semantic Scholar
P561: VIALE-T: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF VENETOCLAX IN COMBINATION WITH AZACITIDINE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
C. Craddock, U. Platzbecker, M. Heuser, V. Pullarkat +7 more
2022HemaSphere6 citations Open access
Semantic Scholar
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
Frank G. Rücker, A. Corbacioglu, J. Krzykalla, S. Cocciardi +22 more
2024HemaSphere5 citations Open access
Semantic Scholar
The Genomic Landscape and Its Clinical Implication in NPM1-Mutated AML Patients: A Study within the AMLSG 09-09 Clinical Trial
S. Cocciardi, Nina Weiß, Maral Saadati, Sabrina Skambraks +20 more
2023Blood5 citations
Semantic Scholar
Phase Ib/II Study (NCT02488408 / BGBC003) of Bemcentinib Monotherapy or in Combination with Cytarabine or Decitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): FINAL Results
S. Loges, M. Heuser, Jolanta Chromik, G. Sutamtewagul +18 more
2023Blood5 citations Open access
Semantic Scholar
Increased late non-cardiac non-relapse mortality in patients with atrial fibrillation diagnosed during hospital stay for allogeneic stem cell transplantation.
Catherina Lueck, V. Panagiota, E. Dammann, R. Gabdoulline +6 more
2022Transplantation and Cellular Therapy5 citations Open access
Semantic Scholar
Single and Combinational Multiplex Base-Edited 'Universal' CAR T Cells in a Humanised Model of Primary CD7+CD33+ AML
A. Kloos, C. Georgiadis, Annie Etuk, S. A. Gkazi +11 more
2022Blood5 citations
Semantic Scholar
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial
U. Duhrsen, Andreas Bockisch, B. Hertenstein, I. Karsten +21 more
2024Blood neoplasia4 citations Open access
Semantic Scholar
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation
Kristin Rathje, N. Gagelmann, R. Salit, T. Schroeder +14 more
2024Bone Marrow Transplantation4 citations Open access
Semantic Scholar
Palbociclib in Acute Leukemias With KMT2A-rearrangement: Results of AMLSG 23-14 Trial
V. Gaidzik, P. Paschka, R. Schlenk, D. Weber +13 more
2023HemaSphere4 citations Open access
Semantic Scholar
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML
Katrin Teich, M. Stadler, R. Gabdoulline, Jyoti Kandarp +14 more
2023Cancers4 citations Open access
Semantic Scholar
Abstract CT026: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced myeloid malignancies
C. Dinardo, P. Montesinos, L. Benajiba, A. Triguero +38 more
2023Cancer Research4 citations
Semantic Scholar
Fla-IDA Chemotherapy with or without Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia
R. Shahswar, G. Beutel, R. Gabdoulline, A. Schwarzer +17 more
2022Blood4 citations Open access
Semantic Scholar
Relapse Prevention in Acute Myeloid Leukemia: The Role of Immunotherapy with Histamine Dihydrochloride and Low-Dose Interleukin-2
P. Montesinos, F. Buccisano, T. Cluzeau, Lovisa Vennström +1 more
2024Cancers3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Döhner×14
Invite
H. Döhner — researcher profile on SciRah
F. Thol×13
Invite
F. Thol — researcher profile on SciRah
K. Döhner×13
Invite
K. Döhner — researcher profile on SciRah
F. Thol×9
Invite
F. Thol — researcher profile on SciRah

×8

Invite

A. Ganser — researcher profile on SciRah

V. Panagiota×7

Invite

V. Panagiota — researcher profile on SciRah

R. Gabdoulline×7

Invite

R. Gabdoulline — researcher profile on SciRah

Invite

A. Benner — researcher profile on SciRah

N. Gagelmann×6

Invite

N. Gagelmann — researcher profile on SciRah

Invite

R. Salit — researcher profile on SciRah

Invite

R. Schlenk — researcher profile on SciRah

Guillermo F. Sanz×5

Invite

Guillermo F. Sanz — researcher profile on SciRah